Når den enkelte patient har nået det terapeutiske mål, bør dosis reduceres med 25- 50% for at fastholde hæmoglobinniveauet.
Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level.